Updated Jul 16, 2026
Collard Craig A has filed 3 SEC Form 4 filings across 2 companies in the last 90 days.
Craig A. Collard is the Chief Executive Officer of Heron Therapeutics, Inc., a biotechnology company focused on developing treatments for unmet patient needs. He has been involved in multiple SEC filings related to his role at the company.
| Role | Director |
|---|---|
| Notability | 30/100 |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-05-04 | HRTX | HERON THERAPEUTICS, INC. /DE/ | M — Option exercise | 50.0K | — | |
| 2026-05-04 | HRTX | HERON THERAPEUTICS, INC. /DE/ | M — Option exercise | 34.8K | — | |
| 2026-04-21 | HRTX | HERON THERAPEUTICS, INC. /DE/ | M — Option exercise | 13.8K | — | |
| 2026-04-06 | HRTX | HERON THERAPEUTICS, INC. /DE/ | M — Option exercise | 62.5K | — | |
| 2026-02-03 | HRTX | HERON THERAPEUTICS, INC. /DE/ | M — Option exercise | 34.8K | — | |
| 2026-01-20 | HRTX | HERON THERAPEUTICS, INC. /DE/ | M — Option exercise | 13.8K | — | |
| 2025-11-04 | HRTX | HERON THERAPEUTICS, INC. /DE/ | M — Option exercise | 34.8K | — | |
| 2025-07-31 | HRTX | HERON THERAPEUTICS, INC. /DE/ | M — Option exercise | 34.8K | — | |
| 2025-07-19 | HRTX | HERON THERAPEUTICS, INC. /DE/ | M — Option exercise | 13.8K | — | |
| 2024-10-21 | HRTX | HERON THERAPEUTICS, INC. /DE/ | M — Option exercise | 13.8K | — |
Craig A. Collard is the Chief Executive Officer of Heron Therapeutics, Inc., a biotechnology company focused on developing treatments for unmet patient needs. He has been involved in multiple SEC filings related to his role at the company.…
3 primary Form 4 filings in the last 90 days, covering 2 companies.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Collard Craig A profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.